Found: 28
Select item for more details and to access through your institution.
Quantitative imaging biomarkers for dural sinus patterns in idiopathic intracranial hypertension.
- Published in:
- Brain & Behavior, 2017, v. 7, n. 2, p. n/a, doi. 10.1002/brb3.613
- By:
- Publication type:
- Article
Detection of Disseminated Aspergillosis on FDG PET/CT in a Patient with Acute Lymphoblastic Leukemia.
- Published in:
- Israel Medical Association Journal, 2018, v. 20, n. 11, p. 717
- By:
- Publication type:
- Article
Ultra-low dose CT abdomen and pelvis for the detection of acute abdominal pathology in the emergency room: initial experience from an academic hospital.
- Published in:
- Emergency Radiology, 2021, v. 28, n. 1, p. 15, doi. 10.1007/s10140-020-01804-2
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 23, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
The contribution of multiparametric pelvic & whole body MR to interpretation of <sup>18</sup>F-fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of <sup>18</sup>F-Fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1253, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 199, doi. 10.1002/cam4.3604
- By:
- Publication type:
- Article
Diagnostic performance of [<sup>18</sup>F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4205, doi. 10.1007/s00259-022-05871-0
- By:
- Publication type:
- Article
Influence of sarcopenia, clinical data, and 2-[<sup>18</sup>F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 3, p. 1012, doi. 10.1007/s00259-021-05514-w
- By:
- Publication type:
- Article
Detection of clinically significant prostate cancer with <sup>18</sup>F-DCFPyL PET/multiparametric MR.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3702, doi. 10.1007/s00259-021-05355-7
- By:
- Publication type:
- Article
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2056, doi. 10.3390/cancers15072056
- By:
- Publication type:
- Article
Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133105
- By:
- Publication type:
- Article
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08796-8
- By:
- Publication type:
- Article